Parkinson's disease: can we influence progression?
Quinn
N
N
D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000494:pharmacology / Q000627:therapeutic use*
D010627:Phenethylamines; D012642:Selegiline